Last update :
18/04/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
Valistab
Valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Antiemetic   Ondansetron hydrochloride  
Injection
Oral solution
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Amal Mexico
Ansentron Brazil
Antivon Chile, Mexico
Atossa Poland
Avessaron Belgium
Axisetron Germany
Bryterol Colombia, Ecuador
Cellondan Germany
Chemoset Morocco
Danac Mexico
Danofran Egypt
Danset Egypt
Dantron Morocco, Republic of South Africa
Dasentron Argentina, Saudi Arabia
Dismolan Argentina, Venezuela
Donset India
Emeset India, Romania, Turkey
Emetron Hungary, Poland
Emistop Mexico, Peru
Indansen Mexico
Nausetron Republic of South Africa
Ondansan Austria
Ondatron Germany
Setronon Croatia
Vomiz Republic of South Africa
Yatrox Spain
Zofer Turkey
Zofran Argentina, Austria, Belgium, Canada, Colombia, Denmark, Ecuador, Egypt, Finland, Germany, Great Britain, Hungary, Iceland, Ireland, Italy, Luxembourg, Malaysia, Morocco, Netherlands, New Zealand, Norway, Peru, Poland, Portugal, Saudi Arabia, Sweden, Switzerland, Turkey, United Arab Emirates, United States of America
Zofron Greece
Zontron Turkey
Zophren France, Tunisia
Zotrix Sweden
Stability in solutions   Injection   Stability in solutions : Ondansetron hydrochloride     
Container Solvent Concentration Temperature Storage Duration of stability References
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,024 & 0,096 mg/ml 21-26°C Light
14 Day
333
Level of evidence A
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,024 & 0,096 mg/ml 4°C - 6°C Protect from light
14 Day
333
Level of evidence A
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,03 & 0,3 mg/ml -20°C Protect from light
90 Day
183
Level of evidence B
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,03 & 0,3 mg/ml 25°C Light
48 Hour
183
Level of evidence B
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,03 & 0,3 mg/ml 4°C Protect from light
14 Day
183
Level of evidence B
Polyvinyl chloride Sodium chloride 0,9% 0,08 mg/ml -20°C Protect from light
120 Day
917
Level of evidence A
Polyvinyl chloride Sodium chloride 0,9% 0,08 mg/ml 4°C Protect from light
120 Day
917
Level of evidence A
Polyvinyl chloride Sodium chloride 0,9% 0,24 mg/ml 30°C Not specified
24 Hour
179
Level of evidence B
Polyvinyl chloride Sodium chloride 0,9% 0,24 mg/ml 3°C Protect from light
30 Day
179
Level of evidence B
Polyvinyl chloride None 2 mg/ml 30°C Not specified
7 Day
179
Level of evidence B
Polypropylen Syringe NaCl 0,9% or Glucose 5% 0,25 & 0,5 & 1 mg/ml -20°C Protect from light
90 Day
915
Level of evidence C
Polypropylen Syringe NaCl 0,9% or Glucose 5% 0,25 & 0,5 & 1 mg/ml 22-25°C Light
48 Hour
915
Level of evidence C
Polypropylen Syringe NaCl 0,9% or Glucose 5% 0,25 & 0,5 & 1 mg/ml 4°C Protect from light
14 Day
915
Level of evidence C
Polypropylen Syringe None 2 mg/ml -20°C Protect from light
90 Day
915
Level of evidence C
Polypropylen Syringe None 2 mg/ml 22-25°C Light
48 Hour
915
Level of evidence C
Polypropylen Syringe None 2 mg/ml 4°C Protect from light
14 Day
915
Level of evidence C
Polyisoprene elastomer NaCl 0,9% or Glucose 5% 0,03 & 0,3 mg/ml 4°C Light
14 Day
113
Level of evidence A
  Mentions Légales